GLPG4716   Click here for help

GtoPdb Ligand ID: 11617

Synonyms: compound 9 [PMID: 33078933]
PDB Ligand
Compound class: Synthetic organic
Comment: GLPG4716 (formerly OATD-01) is a first-in-class, orally bioavailable inhibitor of the chitinase enzymes chitinase 1 (chitotriosidase; CHIT1) and AMCase (chitinase acidic; CHIA) [1]. Galapagos have in-licensed the rights to develop this compound from OncoArendi/Molecure. GLPG4716 was developed as a treatment for respiratory diseases, having demonstrated efficacy in in vivo models of asthma and pulmonary fibrosis, and sarcoidosis. In mid-2022 the Galapagos/Molecure partnership was terminated and all rights for OATD-01 were returned to Molecure.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 4
Topological polar surface area 83.3
Molecular weight 390.19
XLogP 4.53
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C[C@@H]1OC[C@@H](N(C1)C1CCN(CC1)c1nnc([nH]1)N)Cc1ccc(cc1)Cl
Isomeric SMILES C[C@@H]1OC[C@@H](N(C1)C1CCN(CC1)c1nnc([nH]1)N)Cc1ccc(cc1)Cl
InChI InChI=1S/C19H27ClN6O/c1-13-11-26(17(12-27-13)10-14-2-4-15(20)5-3-14)16-6-8-25(9-7-16)19-22-18(21)23-24-19/h2-5,13,16-17H,6-12H2,1H3,(H3,21,22,23,24)/t13-,17-/m0/s1
InChI Key STWVLEKJQQRGMO-GUYCJALGSA-N
Bioactivity Comments
Orally delivered LPG4716 (OATD-01) induces significant antifibrotic effects in an animal model of bleomycin-induced pulmonary fibrosis.
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
chitinase acidic Mm Inhibitor Inhibition 8.1 pIC50 - 1
pIC50 8.1 (IC50 7.8x10-9 M) [1]
chitinase acidic Hs Inhibitor Inhibition 8.1 pIC50 - 1
pIC50 8.1 (IC50 9x10-9 M) [1]
chitinase 1 Hs Inhibitor Inhibition 7.6 pIC50 - 1
pIC50 7.6 (IC50 2.3x10-8 M) [1]
chitinase 1 Mm Inhibitor Inhibition 7.6 pIC50 - 1
pIC50 7.6 (IC50 2.8x10-8 M) [1]